Center for Drug Evaluation and Research Organization Chart - Text Version

February 2024

The following header reflects the organizational hierarchy.

Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research

The following is the Food and Drug Administration, Center for Drug Evaluation and Research organization structure depicting all the organizational structures reporting to the office Director. These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).
 
Each organizational component will be depicted in the following standard format:
 
Title of Organization
Position title of the manager
Public Health Service rank, if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting
Standard Administrative Code

Reports to the FDA Commissioner 
Director
Patrizia Cavazzoni, MD 
(DCD)

The following offices report directly to the Center Director

Office of Regulatory Policy
Director
Carol J. Bennett, JD (Acting)
(DCDB)

Office of Management
Director
Eric Stone, MBA
(DCDC)

Office of Communications           
Director
James-Denton Wyllie
(DCDD)

Office of Surveillance and Epidemiology
Director 
Gerald Dal Pan, MD, MHS
(DCDE)

Office of Compliance
Director
Jill Furman, JD
(DCDF)

Office of New Drugs
Director
Peter P. Stein, MD
(DCDG)

Office of Medical Policy
Director
M. Khair ElZarrad, PhD, MPH
(DCDH)

Office of Executive Programs
Director
Mary Beth Clarke 
(DCDI)

Office of Translational Sciences
Director
ShaAvhree Buckman-Garner, MD, PhD, FAAP
(DCDJ)

Office of Strategic Programs
Director
Jose Galvez (Acting)
(DCDK)

Office of Pharmaceutical Quality
Director
Michael Kopcha, PhD
(DCDL)

Office of Generic Drugs
Director
Iilun C. Murphy, MD
(DCDM)